Clinical Trials Browser

Interventional × Anastrozole × Gynecologic × Clear all

Low Grade Serous Ovarian Cancer

NCT05768139 2026-03-02

PIKALO-1

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT04469764 2025-07-29

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Phase 2 Recruiting

32 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT04719273 2025-01-08

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Phase 2 Active not recruiting

14 enrolled

Gynecologic

Endometrial Neoplasms

NCT02730923 2024-02-13

VICTORIA

Phase 1/2 Unknown

72 enrolled

Gynecologic

Carcinoma, Endometrial Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Clinical Trials

RAMP 301

PIKALO-1

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

VICTORIA

SMMART Adaptive Clinical Treatment (ACT) Trial